参考文献/References:
[1].Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J,2016,37(1):67-119.?
[2].Olschewski H, Simonneau G, Galiè N,et al. Inhaled iloprost for severe pulmonary hypertension[J].N Engl J Med,2002,347(5):322-329.
[3].Martischnig AM, Tichy A, Nikfardjam M, et al. Inhaled iloprost for patients with precapillary pulmonary hypertension and right-side heart failure[J]. J Card Fail,2011,17(10):813-818.
[4].Jing ZC,?Jiang X,?Han ZY, et al. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension[J].Eur Respir J,2009,33(6):1354-1360.
[5].Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension[J]. J Am Coll Cardiol,1999,34(4):1184-1187.
[6].Gomez-Arroyo J, Sakagami M, Syed AA, et al.Iloprost reverses established fibrosis in experimental right ventricular failure[J]. Eur Respir J,2015,45(2):449-462.
[7].Rex S, Missant C, Claus P,et al. Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension[J].Crit Care,2008,12(5):R113.
[8].Baggen VJ,?Leiner T,?Post MC,et al. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis[J]. Eur Radiol,2016,26(11):3771-3780.
[9].Brewi MJ, Bellofiore A, Vanderpool RR, et al.Imaging right ventricular function to predict outcome in pulmonary arterial hypertension[J].Int J Cardiol,2016,218:206-211.
[10].Vonk Noordegraaf A, Westerhof BE, Westerhof N.The relationship between the right ventricle and its load in pulmonary hypertension[J]. J Am Coll Cardiol,2017,69(2):236-243.?
[11].Wauthy P,?Abdel Kafi S,?Mooi WJ, et al. Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension[J].J Thorac Cardiovasc Surg,?2003,126(5):1434-1441.
[12].Holmboe S, Andersen A, Jensen RV, et al. Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heart[J].Pulm Circ,2017,7(2):339-347.
[13].Kemming G, Kisch-Wedel H, Flondor M,et al.Improved ventricular function during inhalation of PGI(2) aerosol partly relies on enhanced myocardial contractility[J].Eur Surg Res,2005,37(1):9-17.
[14].Holmboe S, Andersen A, Vildbrad MD,et al. Iloprost improves ventricular function in the hypertrophic and functionally impaired right heart by direct stimulation[J].Pulm Circ,2013,3(4):870-879.?
[15].Freed BH,?Gomberg-Maitland M,?Chandra S, et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension[J].J Cardiovasc Magn Reson,?2012,14:11.?
[16].Shehata ML,?Lossnitzer D,?Skrok J,et al.Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling[J].AJR Am J Roentgenol,?2011,196(1):87-94.?
[17].van de Veerdonk MC,?Huis In T Veld AE,?Marcus JT, et al. Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension[J].Eur?Respir?J,?2017,49(6).?pii: 1700007. doi: 10.1183/13993003.00007-2017.